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Abstract
Symptoms of orthostatic intolerance (OI) are common in Chronic Fatigue Syndrome (CFS)
and similar disorders. These symptoms may relate to individual differences in intracranial
compliance and cerebral blood perfusion. The present study used phase-contrast, quantita-
tive flow magnetic resonance imaging (MRI) to determine intracranial compliance based on
arterial inflow, venous outflow and cerebrospinal fluid flow along the spinal canal into and
out of the cranial cavity. Flow-sensitive Alternating Inversion Recovery (FAIR) Arterial Spin
Labelling was used to measure cerebral blood perfusion at rest. Forty patients with CFS
and 10 age and gender matched controls were scanned. Severity of symptoms of OI was
determined from self-report using the Autonomic Symptom Profile. CFS patients reported
significantly higher levels of OI (p < .001). Within the patient group, higher severity of OI
symptoms were associated with lower intracranial compliance (r = -.346, p = .033) and
higher resting perfusion (r = .337, p = .038). In both groups intracranial compliance was neg-
atively correlated with cerebral perfusion. There were no significant differences between the
groups in intracranial compliance or perfusion. In patients with CFS, low intracranial compli-
ance and high resting cerebral perfusion appear to be associated with an increased severity
of symptoms of OI. This may signify alterations in the ability of the cerebral vasculature to
cope with changes to systemic blood pressure due to orthostatic stress, but this may not be
specific to CFS.
Introduction
Orthostatic intolerance (OI) refers to symptoms that occur when individuals assume an
upright posture, often from lying down, which are relieved once the individual returns to a
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supine posture including light-headedness, dizziness, blurred vision, headaches or sweating.
They are accompanied by changes in heart rate or blood pressure. In extreme cases OI can
lead to a temporary loss of consciousness (syncope). OI is frequently reported in patients with
Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (ME)[1]. There is also consid-
erable overlap in symptoms between CFS/ME and specific forms of OI such as postural ortho-
static tachycardia syndrome (POTS) [2]. A proportion of CFS/ME patients do have co-morbid
POTS [3] [4], although POTS prevalence may not be higher in CFS than in other fatigued
patients [5]. However, OI symptoms have substantial intraindividual variability in both CFS/
ME [6] and POTS [7], which may complicate precise differential diagnosis.
Due to its high metabolic demand the human brain is particularly vulnerable to blood flow
alterations, and various mechanisms act to maintain relatively stable cerebral perfusion despite
varying systemic blood pressure [8]. Some of these are believed to be active regulatory mecha-
nisms known as cerebral autoregulation [9]. However, passive mechanical properties of cere-
bral tissue also play a major part in regulating the blood pressure-flow relationship [10].
Cerebral autoregulation is believed to be most effective in regulating cerebral blood flow at fre-
quencies well below the heart rate, whereas mechanical properties such as vascular resistance
and intracranial compliance (ICC) affect cerebral blood flow at higher frequencies [11].
Alterations in peripheral vascular compliance have previously been reported in CFS [12],
but it is unknown if this also affects the cerebral vasculature. Given the role of ICC in regulat-
ing the cerebral blood pressure-flow relationship and the fact that CFS patients frequently
report symptoms of OI, we hypothesize a relationship between OI and ICC in CFS.
CFS is also associated with cerebral hypoperfusion [13–16], though this is not a universal
finding [17]. Whether or not this hypoperfusion is related to differences in ICC and may
account for symptoms of OI is not yet clear. We hypothesize that reduced cerebral perfusion is
associated with increased symptoms of OI in CFS and may be related to ICC.
Methods
The current study used magnetic resonance imaging (MRI) techniques to measure intracranial
compliance and cerebral perfusion in a comparatively large sample of patients with CFS and a
sample of age and gender matched control participants. The two groups were compared and
the relationship between the MR based measures and OI were examined.
Participants
A group of 40 patients with CFS (30 female, mean age 45.2 years, range 23–68) participated in
this study as part of a larger project investigating the role of autonomic dysfunctions in CFS.
Participants with CFS were recruited via the Newcastle and North Tyneside National Health
Service (NHS) Clinical CFS Service. Consecutive patients attending the clinic were provided
with a Patient Information Sheet and invited to contact the research team if they were willing
to be involved. Participants were not selected positively or negatively according to any criteria
other than the fact that they were attending the clinical service and had a Fukuda diagnosis of
CFS [18], although they were excluded if they screened positive for a major depressive episode
or other psychiatric condition other than somatoform and anxiety disorders as assessed using
the Structured Clinical Interview for the Diagnostic and Statistical Manual for Mental Disor-
ders [19] (version IV). Other exclusion criteria were use of medication that could affect the
autonomic nervous system, pregnancy, substance abuse in the last 6 months, substance depen-
dence in the last year, certain other medical conditions (e.g. diabetes) and contraindications
for MRI scanning. Basic characteristics of the patient group are provided in Table 1.
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A control group of 10 volunteers (7 female, mean age 49.4 years, range 25–65) were
recruited and matched to the patient group in terms of age and sex. Control participants were
recruited via notices provided in the hospital and University together with a distribution of
posters via the local patient support group. Control participants fulfilled the same inclusion
and exclusion criteria as CFS participants other than the fact that they did not have a CFS diag-
nosis. In addition, controls were required to be sedentary defined as on average not perform-
ing more than 30 minutes a week of moderate exercise. This was meant to ensure that any
potential differences between the groups would not simply be attributable to differences in lev-
els of everyday activity.
All participants gave written informed consent to the study. The study was conducted in
accordance to the Declaration of Helsinki. The study was reviewed and approved by the New-
castle NHS ethics committee (REC 12/NE/0146, CLRN ID 97805).
Table 1. Participant characteristics.
CFS group HV group group difference
Age 45.3 (11.6) 49.4 (15.3) t = 0.941, p = .35
Sex (f/m) 30/10 7/3 χ2 = 0.104, p = .75
BMI 26.0 (5.1) 26.7 (4.6) t = 0.428, p = .67
Mobility level
walk unaided 82.5% (33) 100% (10)
walk with help 17.5% (7) 0% (0)
not mobile 0% (0) 0% (0)
IPAQ
Low 57.5% (23) 20% (2)
Moderate 35.0% (14) 60% (6)
High 2.5% (1) 10% (1)
n/a 5% (2) 10% (1)
MET-score (mean) 725.2 (1006.7) 1403.5 (890.4) t = 1.854, p = .070
MET-score (median) 198.0 1386.0 U = 83.5, p = .017
Years of education 15.5 (3.5) 16.7 (3.6) t = 0.957, p = .34
Employment
unemployed 62.5% (25) 70% (7) χ2 = 0.195a, p = .66
part-time 25% (10) 20% (2)
full-time 12.5% (5) 10% (1)
SF-36 component scores
physical health 23.2 (10.1) 53.4 (10.6) t = 8.340, p < .001
mental health 47.1 (7.0) 55.8 (4.6) t = 4.769, p < .001
Duration of symptoms
years (mean) 13.0 (9.31) -
years (median) 10.5
FIS




Unless otherwise noted, values represent mean and standard deviation (in parentheses). BMI = body mass index; IPAQ = International Physical Activity Questionnaire;
MET = metabolically equivalent task; SF-36 = Medical Outcomes Study 36-item Short Form Health Survey; FIS = Fatigue Impact Scale.
a compared unemployed vs some employment (part or full-time).
https://doi.org/10.1371/journal.pone.0200068.t001
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Orthostatic intolerance assessment
All participants completed the full Autonomic Symptom Profile (ASP) [20]. The resulting sub-
scales of “Orthostatic Intolerance” and “Syncope” were of most relevance for the present
study. As only a small proportion of participants (n = 6) reported any syncope events on the
ASP syncope items (1 item, n = 4; 2 items, n = 2), these two scales were combined into a single
score (OI+Syn).
MRI scanning
Participants were scanned on a 3T Achieva1 (Philips Healthcare, Best, NL) MRI scanner with
an 8-channel head coil. In addition to standard, clinical T1- and T2-weighted anatomical
brain scans, two sets of scans were performed to assess intracranial compliance and perfusion.
For intracranial compliance, a set of three cardiac-gated phase contrast scans were performed
to quantify the intracranial volume and pressure change profile across to the cardiac cycle.
Scans were collected in a single slice (2D spoiled gradient echo sequence, TR = 9.337ms,
TE = 5.64ms, FOV = 200mm x 200mm) positioned at the base of the skull (approximately
lower C1, upper C2 vertebrae) to minimize the influence of neck vessel compliance on the
measurements [21], and placed perpendicular to the internal carotid and vertebral arteries (see
Fig 1A). These scans varied only in the settings of the selected phase encoding velocity through
Fig 1. Quantitative flow imaging and data extraction. A) example slice position; B) example magnitude image with position of blood vessels marked on one side
(ICA = internal carotid artery, JV = jugular vein, VA = vertebral artery); C) phase image at maximum arterial velocity; D) example velocity profiles of selected reference
voxels in right ICA; E) resulting correlation map with positions of reference profiles marked; F) final vessel mask after thresholding of correlation map.
https://doi.org/10.1371/journal.pone.0200068.g001
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the slice (75 cm/s, 40 cm/s, 10 cm/s), and were chosen to maximize the sensitivity of the mea-
surements to arterial, venous and cerebrospinal fluid (CSF) flow. Sixty phases of the cardiac
cycle were acquired with each scan.
Cerebral perfusion was assessed using flow-sensitive alternating inversion recovery (FAIR)
arterial spin labelling (ASL) scans. ASL scans utilized variable-rate selective inversion pulses
[22] and gradient-echo echo-planar-imaging readout (TE = 12.59, TR = 4000ms, voxel size
4x4x6 mm3, 10 axial slices). Sixty tag-control image pairs were acquired with a post inversion
delay of 1500ms. Additional inversion recovery scans with inversion times of 900, 1200, 1800,
2100 and 2400ms were acquired for T1 estimation.
Intracranial compliance analysis
ICC calculations were based on the measured velocities in four arteries (left and right internal
carotid, left and right vertebral artery), the left and right internal jugular vein and the CSF flow
along the spinal canal as previously described [23]. For each vessel/lumen the set of phase
images was selected that offered the highest dynamic range, yet eliminated or minimized the
number of voxels exhibiting velocity aliasing in the lumen of interest. In rare cases, voxels with
aliased velocity profiles were automatically corrected. The identification of lumen areas used a
semi-automatic approach that separated background tissue voxels from vessel voxels based on
cross-correlation with manually selected reference flow profiles (Fig 1C–1E) of voxels within
each lumen [24]. Cut-offs for correlation coefficients were determined manually for each
lumen, aided by visual depiction of the coefficient distribution.
Velocity profiles were extracted for each of the selected voxels. These were then used to cal-
culate arterial inflow, venous outflow, CSF flow and the intracranial volume change profile
(ΔV(t) in ml), which measures the compression and expansion of intracranial tissue due to the
differential inflow and outflow of fluids to and from the cranial cavity. As only a limited num-
ber of blood vessels were assessed, this profile was corrected such that cumulative inflows and
outflows over the full cardiac cycle were equal. The overall peak-to-peak volume change was
used in the compliance calculation. Flow-velocities of the CSF were used to calculate a pressure
gradient profile (ΔP(t)/d) as described elsewhere [25]. The peak-to-peak pressure gradient dif-
ference (in mmHgcm-1) of this profile was used to calculate the intracranial compliance index
(ICCI), which divided the peak-to-peak volume change by peak-to-peak pressure gradient.
Cerebral perfusion analysis
ASL images were re-aligned to the first scan and co-registered to the anatomical scan using
rigid-body transformations. All subsequent ASL processing was based on extracted signal lev-
els from the grey matter segment, which was derived from a high-resolution anatomical scan
using standard segmentation routines implemented in SPM8 (http://www.fil.ion.ucl.ac.uk/
spm/). The average tag-control signal level difference of the FAIR scans was used to calculate
blood perfusion values according to a standard kinetic model [26]. Additional parameters for
these calculations were based on published findings [27] [28] [29].
Statistical analysis
Statistical analysis was performed in SPSS version 21 (International Business Machines Corp.,
Armonk, NY, USA). Group comparisons were performed using parametric tests (t-test,
ANCOVA), with the exception of ASP scores, which utilized a non-parametric rank test.
Within groups, Pearson bivariate and partial correlations were calculated to assess relation-
ships among the measures.
Intracranial compliance and orthostatic intolerance in CFS
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Results
Group comparisons
OI+Syn scores are shown in Fig 2A. As expected, there were clear differences between CFS
patients and controls. Only two of 40 patients reported not having any symptoms (i.e. score of
0). The remainder of the patient group reported symptoms ranging from score 2 to score 16.
Patients had a mean OI+Syn score of 9.33 (SD = 4.05; median = 10). On the other hand, eight
of the ten controls reported no symptoms with the remaining two reporting mild symptoms
with scores of 3 and 8 respectively (mean = 1.30, SD = 2.98, median = 0). There was a signifi-
cant difference in OI+Syn score between the two groups (Mann-Whitney U = 31.0, p< .001).
ICCI are shown in Fig 2B. In the CFS group ICCI ranged from 3.59 to 24.06 ml/mmHg
cm-1 (mean = 11.18, SD = 5.22, median = 10.62). In the control group ICCI ranged from 4.08
to 22.31 ml/mmHgcm-1 (mean = 11.83, SD = 6.55, median = 10.28). There was no significant
difference in ICCI between the two groups, t(49) = 0.339, p = .74. Grey matter CBF (Fig 2C)
ranged from 49.0 to 95.2 ml/100gmin (mean = 71.4, SD = 11.4, median = 69.6) in the CFS
group, and from 47.9 to 91.6 ml/100gmin (mean = 72.4, SD = 14.6, median = 76.1) in the
control group. Controlling for sex, there was no significant difference between the two groups,
F(1,47)<1.
Relationships between OI, compliance and CBF
Correlations were computed in the CFS group between ICCI, grey matter CBF, the ASP OI
+Syn score, age and sex. This showed a negative correlation between OI+Syn and ICCI, r =
-.386, p = .013, and a positive correlation between OI+Syn and CBF, r = .417, p = .007. ICCI
and CBF also correlated highly, r = -.406, p = .009. Furthermore, age was significantly corre-
lated with OI+Syn, r = -.326, p = .037, and with CBF, r = -.486, p = .001; sex was significantly
correlated with CBF, r = -.381, p = .015. Because of the influences of the demographic factors
on both orthostatic symptoms and the MRI-based measures, partial correlations were com-
puted controlling for age and sex.
Within the patient group, the partial correlations between OI+Syn and ICCI, r = -.346, p =
.033, between OI+Syn and CBF, r = .337, p = .038, and between CBF and ICCI, r = -.337, p =
.036, were all significant. In controls, there was a negative partial correlation between ICCI
and CBF, r = -.737, p = .037. Fig 3 shows scatter plots of these relationships (using residual
plots after accounting for influences of age and sex).
As ICC is measured as a ratio of changes in intracranial volume and pressure, we explored
if these two components were individually associated with OI in the patient group. Covarying
for age and sex, there was a trend for a positive relationship between the peak-to-peak pressure
gradient and orthostatic symptoms, r = .302, p = .065, but not between peak-to-peak volume
change and orthostatic symptoms, r = -.146, p = .38. The peak-to-peak pressure gradient itself
was negatively correlated with diastolic blood pressure at supine rest, r = -.352, p = .030. How-
ever, blood pressure itself was unrelated to orthostatic symptoms (p = .57 for systolic and p =
.74 for diastolic blood pressure) or ICCI (systolic p = .46, diastolic p = .74).
Discussion
The current study indicates a potential role of ICC in the severity of symptoms of OI in
patients with CFS. As expected, almost all CFS patients in our sample reported various levels
of OI via self-report that were significantly higher than those reported by the healthy control
group. In the patient group there was a negative relationship between OI symptom severity
and ICC, as those patients with higher compliance tended to report lower OI symptoms (and
Intracranial compliance and orthostatic intolerance in CFS
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vice versa). Furthermore, there was a positive correlation between orthostatic symptoms and
cerebral blood perfusion in grey matter. This suggests that CFS patients who report more
severe orthostatic symptoms have higher levels of resting cerebral perfusion than those
patients who report fewer or only milder orthostatic symptoms.
While, as expected, orthostatic symptom severity was significantly higher in the patient
group than in healthy controls, ICC did not differ between the two groups. A previous study
that used very similar MR methods was also unable to find differences between CFS patients
and controls in pulsatile CSF flow parameters [30]. Similarly, there was no significant differ-
ence between the groups in grey matter cerebral perfusion. This contradicts several earlier
findings that have reported reduced perfusion in CFS patients [16, 31, 32]. However, reports of
Fig 2. Group comparisons. Group comparisons of orthostatic intolerance (A), intracranial compliance (B) and
cerebral perfusion (C).
https://doi.org/10.1371/journal.pone.0200068.g002
Fig 3. Residual scatter plots. (A) Relationship between OI and ICCI in the patient group. (B) Relationship between OI
and CBF in the patient group. (C) Relationship between CBF and ICCI in the patient group, and (D) the control group.
All scores were adjusted for effects of age and sex.
https://doi.org/10.1371/journal.pone.0200068.g003
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cerebral hypoperfusion are not universal as other studies have also reported regional cerebral
hyperperfusion in CFS [33]. It is important to note that the present study only investigated
average grey matter perfusion across the whole brain and it cannot be excluded that regional
hypo- or hyperperfusion were present. Furthermore, not all of the above studies have excluded
CFS patients with comorbid depression, whereas the current study did so explicitly. As depres-
sion has been associated with cerebral hypoperfusion[34], some of the reported findings may
in part be due to depression and not chronic fatigue.
While the relatively small size of our control group may have prevented us from identifying
group differences in compliance or perfusion, even the mean values were numerically very
close to each other so that a simple lack of statistical power is unlikely be the sole reason for
not finding group differences. It should however be noted that our control group was deliber-
ately recruited to be mostly sedentary and therefore may not have been at optimum levels
of general health itself. Furthermore, the relationship between ICC and cerebral perfusion
appeared to be very similar in both groups. This suggests that ICC and cerebral perfusion
were not altered in our CFS patients relative to the control group. Instead it appears that low
intracranial compliance, which was strongly negatively coupled to higher resting perfusion, is
associated with experiencing higher severity of symptoms of OI in the CFS group if the cardio-
vascular system is not capable of providing adequate blood supply to the brain due to an ortho-
static stressor.
The negative relationship between ICC and cerebral perfusion may seem puzzling at first.
However, given that the ICCI is inversely proportional to the peak-to-peak pressure gradient,
lower compliance may be an expression of larger pressure gradients, which may increase
blood perfusion. Indeed, in patients there is a significant positive correlation between CBF and
the peak-to-peak pressure gradient, but not with peak-to-peak intracranial volume change. In
contrast, CBF in controls showed a significantly negative correlation with intracranial volume
change (r = -.826, p = .012), but no significant correlation with peak-to-peak pressure gradient
(r = .468, p = .24). In other words, the negative relationship between ICC and cerebral perfu-
sion appears to be primarily determined by pressure differences in patients, whereas it is pri-
marily determined by volume changes in controls.
It should also be noted that CBF and compliance measurements were made at rest while
participants were in a supine position on the MR scanner bed. A study in healthy volunteers
using a low-field, vertical gap MRI scanner and comparing a supine to an upright posture
showed that these parameters are indeed posture dependent [35]. It is conceivable that the
supine posture of the current study had increased cerebral perfusion in low compliance, high
OI symptom patients, and that their cerebral perfusion measurements would have been similar
to high-compliance/low OI symptom patients had the perfusion measurement been taken in
an upright position. While it is not possible to dynamically change a subject’s position from
supine to upright in current high-field MR scanners, other techniques such as lower-body neg-
ative pressure or thigh-cuff deflation could be utilized in future studies to simulate different
orthostatic conditions and their effect on cerebral perfusion.
However, studies using transcranial Doppler ultrasonography showed that patients with
POTS and healthy controls have near identical blood flow velocities in the middle cerebral
artery, which decreased equally with increasing levels of tilt [36, 37]. Instead, POTS patients
showed an increase in low-frequency oscillatory blood flow with increasing levels of tilt,
whereas controls did not. The authors argued that these increased low-frequency oscillations
are an expression of impaired cerebral autoregulation and that they might interfere with nor-
mal neurovascular coupling [37]. Low ICC in our high-OI patients may have put a limit on
their ability for dynamic cerebral autoregulation, thereby resulting in similar low-frequency
blood flow oscillations. Furthermore, as (intracranial or vascular) compliance is directly
Intracranial compliance and orthostatic intolerance in CFS
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responsible for dampening BP oscillations at high frequencies (at and above heart rate), low
ICC could increase the amount of pressure oscillation that is transmitted to perivascular cere-
bral tissue at these higher frequencies and might cause similar interference with normal neuro-
vascular coupling as those hypothesized for low-frequency oscillations.
In summary, we present evidence for a relationship between the degree of self-reported
severity of orthostatic intolerance in patients with chronic fatigue syndrome and MRI based
measures of intracranial compliance and cerebral blood perfusion. Patients with more severe
OI symptoms exhibited lower levels of ICC and higher levels of cerebral perfusion. While nei-
ther of those measures was significantly different from the control group and an inverse rela-
tionship between compliance and perfusion was observed in both CFS patients and in
controls, reduced ICC may constitute a risk factor for experiencing symptoms of orthostatic
intolerance as it might reduce an individual’s ability for effective cerebral autoregulation.
Whether the supine posture in the MR scanner had elevated cerebral perfusion in individuals
with low compliance remains unclear and should be the subject of further investigation. Future
studies should attempt to replicate these findings perhaps using more (clinically) accessible
methods such as transcranial Doppler ultrasonography. If a link between the severity of ortho-
static symptoms and ICC can be replicated, this would suggest that patients who experience
severe symptoms of OI should be investigated for low levels of ICC. It could then also be inves-
tigated whether treatments that raise ICC have ameliorating effects on orthostatic symptoms.
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